ENARA BIO
Enara Bio is a science-led company targeting the T-cell/cancer cell interface (the โimmune synapseโ) to develop new targeted cancer immunotherapies designed to treat a broad patient population. Enara Bio focuses on discovering and developing therapeutic cancer vaccines utilizing novel antigens derived from endogenous retroviral (ERV)-related DNA sequences.
ENARA BIO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.enarabio.com
Total Employee:
11+
Status:
Active
Total Funding:
17.5 M USD
Technology used in webpage:
SPF GoDaddy DNS Digital Ocean Mimecast KnowBe4 Smartsheet
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
SV Health Investors
SV Health Investors investment in Series A - Enara Bio
RA Capital Management
RA Capital Management investment in Seed Round - Enara Bio
Key Employee Changes
Date | New article |
---|---|
2022-02-01 | Enara Bio announces the appointment of T-cell therapy leader Dr. Sophie Papa as Chief Medical Officer |
Official Site Inspections
http://www.enarabio.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.29 K
- Host name: 138.68.116.208
- IP address: 138.68.116.208
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1